Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. Co. has developed a resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL™, has various potential indications of use for diseases, which of Co. is primarily targeting Mucopolysaccharidoses Type 1, Friedreich's Ataxia, and Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes syndrome and with Amyotrophic Lateral Sclerosis in an early development stage. In the larger disease areas, Co. is primarily targeting Mild Cognitive Impairment/early Alzheimer's disease with Traumatic Brain Injury /concussions and Covid-19 in early development stages. We show 3 historical shares outstanding datapoints in our JUNS shares outstanding history coverage, used to compute JUNS market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing JUNS market cap history over the course of time is important for investors
interested in comparing JUNS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of JUNS versus a peer is one thing; comparing
JUNS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like JUNS can fluctuate over the course of history.
With this page we aim to empower investors researching JUNS by allowing them to research the JUNS market cap history. |
Free JUNS Email Alerts:
Video: The Importance of Market Cap
